Maxygen, Inc.Redwood City, CA, United States (NASDAQ (GM): MAXY)

Tools:

Buy A ReportBecome A Subscriber

Today's Special Offer

Maxygen Financial Statements

Maxygen Financial Information

Company Type Public
Headquarters
Fiscal Year-End December
© 2009 Morningstar, Inc. Financial Data provided by Morningstar

Maxygen Income Statement

  2008 2007 2006
Revenue ($ mil.) 100.7 23.2 25.0
Gross Profit ($ mil.) -- -- --
Operating Income ($ mil.) -- -- --
Total Net Income ($ mil.) 30.3 (49.3) (16.5)
Diluted EPS (Net Income) 0.81 (1.34) (0.46)
More Maxygen financial information

Maxygen Quarterly Statements

  Quarter Ending Jun 09 Quarter Ending Mar 09 Quarter Ending Dec 08
Revenue ($ mil.) 6.8 8.5 6.0
Gross Profit ($ mil.) -- -- --
Operating Income ($ mil.) -- -- --
Total Net Income ($ mil.) (5.9) (1.1) (7.7)
Diluted EPS (Net Income) (0.15) (0.03) (0.21)
More Maxygen financial information

Maxygen Stock Quote & Chart

11/06/09 16:00:01 EST • NASDAQ • 5.70 • Decreased by -0.1700 • Decreased by -2.8961 %
Quotes delayed 15 minutes for NASDAQ. 20 minutes for NYSE and AMEX. Market Data provided by Interactive Data. Powered and Implemented by Interactive Data Managed Solutions.
Detailed QuoteInteractive Stock Chart

Maxygen Financial Ratios

  Company Industry
Median
Market
Median1
Price/Sales Ratio 1.96 7.49 7.00
Price/Earnings Ratio 3.41 92.59 25.45
Price/Book Ratio 1.17 3.46 6.74
Price/Cash Flow Ratio 2.91 41.15 43.48
1 Public companies trading on the New York Stock Exchange, the American Stock Exchange, and the NASDAQ National Market.

Detailed Maxygen Financial Ratios

Maxygen Competitive Intelligence

Eli Lilly Genentech Human Genome Sciences
Annual Sales ($ mil.) 20,378.0 13,418.0 48.4
Employees 40,500 11,174 880
Market Cap ($ mil.) 39,560.8 -- 4,549.4

Competitive Landscape

Copyright © 2009, Hoover's, Inc., All Rights Reserved. Legal Terms | Privacy Policy